These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 27094004)
1. [Advances in molecular genetics pathogenesis of splenic marginal zone lymphoma]. Yan Y; Yi S; Qiu L Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):348-52. PubMed ID: 27094004 [No Abstract] [Full Text] [Related]
2. MicroRNA expression profile in splenic marginal zone lymphoma. Bouteloup M; Verney A; Rachinel N; Callet-Bauchu E; Ffrench M; Coiffier B; Magaud JP; Berger F; Salles GA; Traverse-Glehen A Br J Haematol; 2012 Jan; 156(2):279-81. PubMed ID: 21902683 [No Abstract] [Full Text] [Related]
3. Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas. Mian M; Kwee I; Rinaldi A; Ponzoni M; Bhagat G; Rossi D; Arcaini L; Gascoyne RD; Mollejo M; Baldini L; Thieblemont C; Gaidano G; Zucca E; Bertoni F Br J Haematol; 2014 Mar; 164(6):896-9. PubMed ID: 24329863 [No Abstract] [Full Text] [Related]
4. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone. de Wolf-Peeters C; Pittaluga S; Dierlamm J; Wlodarska I; Van Den Berghe H Leuk Lymphoma; 1997 Aug; 26(5-6):467-78. PubMed ID: 9389354 [TBL] [Abstract][Full Text] [Related]
5. De novo large B-cell lymphoma in a parenchymal brain lesion: evidence of clonal evolution from splenic marginal zone lymphoma. Fadugba O; Nguyen TT; McGill J; Wagner-Johnston N J Clin Oncol; 2011 Mar; 29(9):e234-6. PubMed ID: 21205746 [No Abstract] [Full Text] [Related]
6. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation. Martínez N; Almaraz C; Vaqué JP; Varela I; Derdak S; Beltran S; Mollejo M; Campos-Martin Y; Agueda L; Rinaldi A; Kwee I; Gut M; Blanc J; Oscier D; Strefford JC; Martinez-Lopez J; Salar A; Sole F; Rodriguez-Peralto JL; Diez-Tascón C; García JF; Fraga M; Sebastián E; Alvés J; Menárguez J; González-Carreró J; Casado LF; Bayes M; Bertoni F; Gut I; Piris MA Leukemia; 2014 Jun; 28(6):1334-40. PubMed ID: 24296945 [TBL] [Abstract][Full Text] [Related]
8. Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma. Hockley SL; Morilla A; Else M; Dearden C; Catovsky D; Morgan GJ; Matutes E; Gonzalez D Leukemia; 2010 May; 24(5):1084-6. PubMed ID: 20237507 [No Abstract] [Full Text] [Related]
9. Primary nodal marginal zone lymphomas of splenic and MALT type. Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704 [TBL] [Abstract][Full Text] [Related]
10. An insidious presentation of splenic marginal zone lymphoma. Burcheri S; Arcaini L; Della Porta M; Paulli M; Boveri E; Zibellini S; Rumi E; Algarotti A; Passamouti F; Lazzarino M Clin Lymphoma Myeloma; 2007 May; 7(6):432-3. PubMed ID: 17621411 [TBL] [Abstract][Full Text] [Related]
11. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation. Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947 [TBL] [Abstract][Full Text] [Related]
12. Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine. Scapinello G; Pizzi M; Vio S; Nabergoj M; Visentin A; Martines A; Bonaldi L; Trentin L; Semenzato G; Piazza F Ann Hematol; 2018 Oct; 97(10):2001-2003. PubMed ID: 29728736 [No Abstract] [Full Text] [Related]
13. Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns. Hockley SL; Giannouli S; Morilla A; Wotherspoon A; Morgan GJ; Matutes E; Gonzalez D Br J Haematol; 2010 Feb; 148(4):666-9. PubMed ID: 19863540 [No Abstract] [Full Text] [Related]
14. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis. Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527 [TBL] [Abstract][Full Text] [Related]
15. Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling. Arribas AJ; Gómez-Abad C; Sánchez-Beato M; Martinez N; Dilisio L; Casado F; Cruz MA; Algara P; Piris MA; Mollejo M Mod Pathol; 2013 Jul; 26(7):889-901. PubMed ID: 23429603 [TBL] [Abstract][Full Text] [Related]
16. A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders. Brisou G; Verney A; Wenner T; Baseggio L; Felman P; Callet-Bauchu E; Coiffier B; Berger F; Salles G; Traverse-Glehen A Haematologica; 2014 Oct; 99(10):e197-8. PubMed ID: 24997147 [No Abstract] [Full Text] [Related]
17. Clonally related splenic marginal zone lymphoma and Hodgkin lymphoma with unmutated V gene rearrangements and a 15-yr time gap between diagnoses. Rosenquist R; Roos G; Erlanson M; Küppers R; Bräuninger A; Hansmann ML Eur J Haematol; 2004 Sep; 73(3):210-4. PubMed ID: 15287919 [TBL] [Abstract][Full Text] [Related]
18. The genetics of nodal marginal zone lymphoma. Spina V; Khiabanian H; Messina M; Monti S; Cascione L; Bruscaggin A; Spaccarotella E; Holmes AB; Arcaini L; Lucioni M; Tabbò F; Zairis S; Diop F; Cerri M; Chiaretti S; Marasca R; Ponzoni M; Deaglio S; Ramponi A; Tiacci E; Pasqualucci L; Paulli M; Falini B; Inghirami G; Bertoni F; Foà R; Rabadan R; Gaidano G; Rossi D Blood; 2016 Sep; 128(10):1362-73. PubMed ID: 27335277 [TBL] [Abstract][Full Text] [Related]
19. Splenic marginal zone lymphoma. Piris MA; Onaindía A; Mollejo M Best Pract Res Clin Haematol; 2017; 30(1-2):56-64. PubMed ID: 28288718 [TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: new therapeutic opportunities. Arcaini L; Rossi D Haematologica; 2012 May; 97(5):638-40. PubMed ID: 22556352 [No Abstract] [Full Text] [Related] [Next] [New Search]